You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 106 No. 11, November 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Heterogeneity in macular corneal dystrophy

D. P. Edward, B. Y. Yue, J. Sugar, E. J. Thonar, N. SunderRaj, E. L. Stock and M. O. Tso
Department of Ophthalmology, University of Illinois College of Medicine, Chicago 60612.

Macular corneal dystrophy is an autosomal recessive disorder in which abnormal deposits in the corneal stroma have been identified. We examined the corneal buttons of 12 patients, who had clinical features of macular dystrophy, by histochemical staining, transmission electron microscopy, and immunohistochemical techniques. All corneas exhibited positive staining with Muller Mowry's colloidal iron. Using monoclonal antibodies 1/20/5-D-4, J-10, J-19, and J-36 that recognize specific sites on the sulfated keratan sulfate molecule, we stained corneal sections by an avidin-biotin-peroxidase complex method and identified two groups of macular corneal dystrophy. One group consisting of four corneas reacted positively with all four antibodies, and the other group consisting of eight corneas did not react with any of the antibodies used. These results confirmed those recently presented by Yang et al that there may be subgroups of macular dystrophy that can be identified by immunohistochemical methods. Also, serum levels of sulfated keratan sulfate were determined in seven patients. One patient who displayed a normal level of serum keratan sulfate had positive corneal immunoreactivity. Of the six patients who lacked serum keratan sulfate, four showed negative and two had positive corneal immunostaining, suggesting at least three subgroups in the disease. An attempt was made to correlate the clinical features, histochemical-staining characteristics, and ultrastructural morphology with the immunoreactivity to keratan sulfate antibodies, but no correlations could be made.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Secretion and Organization of a Cornea-like Tissue In Vitro by Stem Cells from Human Corneal Stroma
Du et al.
IOVS 2007;48:5038-5045.
ABSTRACT | FULL TEXT  

Multipotent Stem Cells in Human Corneal Stroma
Du et al.
Stem Cells 2005;23:1266-1275.
ABSTRACT | FULL TEXT  

Mutations in the CHST6 Gene in Patients with Macular Corneal Dystrophy: Immunohistochemical Evidence of Heterogeneity
Iida-Hasegawa et al.
IOVS 2003;44:3272-3277.
ABSTRACT | FULL TEXT  

Altered Fine Structures of Corneal and Skeletal Keratan Sulfate and Chondroitin/Dermatan Sulfate in Macular Corneal Dystrophy
Plaas et al.
J. Biol. Chem. 2001;276:39788-39796.
ABSTRACT | FULL TEXT  

Decreased GlcNAc 6-O-Sulfotransferase Activity in the Cornea with Macular Corneal Dystrophy
Hasegawa et al.
IOVS 2000;41:3670-3677.
ABSTRACT | FULL TEXT  

Characterization and Expression of the Mouse Lumican Gene
Ying et al.
J. Biol. Chem. 1997;272:30306-30313.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.